We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
–
Increased
6
Reduced
3
Closed
920

Top Buys

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$184M
2
FHN icon
First Horizon
FHN
+$107M
3
SGFY
Signify Health, Inc.
SGFY
+$54.9M
4
VMW
VMware, Inc
VMW
+$34.9M
5
ONEM
1Life Healthcare
ONEM
+$29.7M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$572M
2
ZEN
ZENDESK INC
ZEN
+$456M
3
ROG icon
Rogers Corp
ROG
+$432M
4
AVLR
Avalara, Inc.
AVLR
+$373M
5
SWCH
Switch, Inc. Class A Common Stock
SWCH
+$271M

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLNC icon
126
Fluence Energy
FLNC
$1.75B
– –
-50,000
Closed -$730K
FLYX icon
127
flyExclusive
FLYX
$63.7M
– –
-190,155
Closed -$1.86M
FR icon
128
First Industrial Realty Trust
FR
$8.4B
– –
-80,397
Closed -$3.6M
FSLR icon
129
First Solar
FSLR
$26.2B
– –
-62,420
Closed -$8.26M
GILD icon
130
Gilead Sciences
GILD
$162B
– –
-53,000
Closed -$3.27M
GKOS icon
131
Glaukos
GKOS
$10.1B
– –
-32,692
Closed -$1.74M
GLPI icon
132
Gaming and Leisure Properties
GLPI
$12.8B
– –
-97,085
Closed -$4.29M
GLUE icon
133
Monte Rosa Therapeutics
GLUE
$1.33B
– –
-91,615
Closed -$748K
GM icon
134
General Motors
GM
$76.3B
– –
-20,951
Closed -$672K
GRAB icon
135
Grab
GRAB
$15B
– –
-1,086,000
Closed -$2.86M
GRND icon
136
Grindr
GRND
$3.05B
– –
-459,569
Closed -$4.77M
GSK icon
137
GSK
GSK
$104B
– –
-165,076
Closed -$4.86M
GSK icon
138
PUT
GSK
GSK
$104B
– –
-48,500
Closed -$381K
GTLS
139
DELISTED
Chart Industries
GTLS
– –
-22,950
Closed -$4.23M
H icon
140
PUT
Hyatt Hotels
H
$16.9B
– –
-17,500
Closed -$59K
HALO icon
141
Halozyme
HALO
$10.2B
– –
-83,937
Closed -$3.32M
HASI icon
142
PUT
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.89B
– –
-220,000
Closed -$314K
HD icon
143
Home Depot
HD
$349B
– –
-4,290
Closed -$1.18M
HGV icon
144
Hilton Grand Vacations
HGV
$3.61B
– –
-111,153
Closed -$3.66M
HIW icon
145
Highwoods Properties
HIW
$3.47B
– –
-99,622
Closed -$2.69M
HLN icon
146
Haleon
HLN
$44.2B
– –
-183,814
Closed -$1.12M
HLT icon
147
PUT
Hilton Worldwide
HLT
$72.5B
– –
-13,500
Closed -$107K
HLVX
148
DELISTED
HilleVax
HLVX
– –
-60,943
Closed -$1.04M
HPP
149
Hudson Pacific Properties
HPP
$729M
– –
-62,038
Closed -$4.75M
HUMA icon
150
Humacyte
HUMA
$191M
– –
-595,172
Closed -$1.94M
4 5
6
7 8

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.